Scorpion Therapeutics
Erica Jackson is currently the Chief Discovery Officer and Executive Vice President, Target Biology at Scorpion Therapeutics. Prior to this, Erica held positions such as Senior Director at AbbVie, Head of Biology at Pharmacyclics, Director of Biology at ORIC Pharmaceuticals, and various roles at Genentech. Erica completed their PhD in Biology at the Massachusetts Institute of Technology after obtaining their BA in Biology from Brandeis University.
This person is not in any offices
Scorpion Therapeutics
1 followers
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments.